Skip to main content

Table 2 Neisseria gonorrhoeae with decreased susceptibility or resistance to cefixime or ceftriaxone (≥0.125) isolated in Hanoi, Vietnam in 2011 (n = 30)

From: Antimicrobial susceptibility and genetic characteristics of Neisseria gonorrhoeae isolates from Vietnam, 2011

NG-MAST

Minimum inhibitory concentration

penAalteration

mtrRalteration

PorB1b (penBalteration)

 

Cefixime

Ceftriaxone

A501 alteration (penAallele [[16]])

A-deletion in promoter region

MtrR coding region

G101

A102

ST4787 (n = 1)

0.25

0.25

T (XVIII)

Yes

A39T

K

D

ST4787 (n = 2)

0.125

0.25

T (XVIII)

Yes

A39T

K

D

ST4787 (n = 1)

0.125

0.125

V (A501 New**)

Yes

H105Y

K

D

ST4787 (n = 3)

0.064

0.125

T (XVIII)

Yes

A39T

K

D

ST4787 (n = 1)

0.032

0.125

T (XVIII)

Yes

A39T

K

D

ST7159 (n = 2)

0.064

0.125/0.25

T (XVIII)

Yes

D79N T86A H105Y

K

D

ST4676 (n = 1)

0.125

0.25

T (XVIII)

Yes

H105Y

K

G

3 STsa (n = 4)

0.125

0.125

T (XVIII)

Yes

A39T

K/Db

D/Gb

12 STs (n = 15)

0.064

0.125

T/V/WTc

Yes

A39T G45D H105Yd

K/D/Te

D/G/WTe

  1. NG-MAST, Neisseria gonorrhoeae multiantigen sequence typing; ST, sequence type.
  2. a ST7739 (n = 2), ST7160 (n = 1) and ST7741 (n = 1).
  3. b G101D/A102G (n = 2) and G101K/A102D (n = 1).
  4. c A501V New** (n = 9), XVIII (n = 3), XIII (n = 2) and XII (n = 1).
  5. d H105Y (n = 8), A39T (n = 4), and G45D (n = 3).
  6. e G101K/A102D (n = 11), G101D/A102G (n = 2), G101D/WT (n = 1), G101T/A102D (n = 1).